DK100886D0 - Antibiotiske clathrater - Google Patents
Antibiotiske clathraterInfo
- Publication number
- DK100886D0 DK100886D0 DK100886A DK100886A DK100886D0 DK 100886 D0 DK100886 D0 DK 100886D0 DK 100886 A DK100886 A DK 100886A DK 100886 A DK100886 A DK 100886A DK 100886 D0 DK100886 D0 DK 100886D0
- Authority
- DK
- Denmark
- Prior art keywords
- clathrater
- antibiotic
- antibiotic clathrater
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/750,718 US4663316A (en) | 1985-06-28 | 1985-06-28 | Antibiotic clathrates and pharmaceutical compositions thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DK100886D0 true DK100886D0 (da) | 1986-03-05 |
DK100886A DK100886A (da) | 1986-12-29 |
Family
ID=25018911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK100886A DK100886A (da) | 1985-06-28 | 1986-03-05 | Antibiotiske clathrater |
Country Status (8)
Country | Link |
---|---|
US (1) | US4663316A (da) |
EP (1) | EP0206490B1 (da) |
JP (1) | JPS624293A (da) |
AU (1) | AU581061B2 (da) |
CA (1) | CA1237125A (da) |
DE (1) | DE3669517D1 (da) |
DK (1) | DK100886A (da) |
ZA (1) | ZA862575B (da) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5130445A (en) * | 1984-03-26 | 1992-07-14 | Merck & Co., Inc. | Antifungal substances and process for their production |
US4663316A (en) * | 1985-06-28 | 1987-05-05 | Warner-Lambert Company | Antibiotic clathrates and pharmaceutical compositions thereof |
JPS6333341A (ja) * | 1986-07-28 | 1988-02-13 | Seitetsu Kagaku Co Ltd | 配糖体の処理方法 |
US4877774A (en) * | 1987-09-09 | 1989-10-31 | The United States Of America As Represented By The Department Of Health And Human Services | Administration of steroid hormones |
US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
US5017566A (en) * | 1987-12-30 | 1991-05-21 | University Of Florida | Redox systems for brain-targeted drug delivery |
US5997856A (en) * | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
US5053240A (en) * | 1989-10-24 | 1991-10-01 | Kalamazoo Holdings, Inc. | Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides |
CA2013485C (en) * | 1990-03-06 | 1997-04-22 | John Michael Gardlik | Solid consumer product compositions containing small particle cyclodextrin complexes |
US5246611A (en) * | 1990-05-09 | 1993-09-21 | The Procter & Gamble Company | Non-destructive carriers for cyclodextrin complexes |
US5384186A (en) * | 1990-05-09 | 1995-01-24 | The Proctor & Gamble Company | Non-destructive carriers for cyclodextrin complexes |
US5139687A (en) * | 1990-05-09 | 1992-08-18 | The Proctor & Gamble Company | Non-destructive carriers for cyclodextrin complexes |
US20040014695A1 (en) * | 1992-06-19 | 2004-01-22 | Supergen, Inc. | Pharmaceutical formulation |
US5602112A (en) | 1992-06-19 | 1997-02-11 | Supergen, Inc. | Pharmaceutical formulation |
US5824668A (en) * | 1996-11-07 | 1998-10-20 | Supergen, Inc. | Formulation for administration of steroid compounds |
US6287603B1 (en) | 1999-09-16 | 2001-09-11 | Nestec S.A. | Cyclodextrin flavor delivery systems |
IT1319666B1 (it) * | 2000-11-17 | 2003-10-23 | Pharma Biotech Ltd | Addotti di antibiotici con polimeri polisaccaridici naturali in formadi soluzioni acquose. |
BRPI0612032A2 (pt) * | 2005-06-13 | 2010-10-13 | Cargill Inc | complexos de inclusão de ciclodextrina e métodos de preparação dos mesmos |
JP2008543831A (ja) * | 2005-06-13 | 2008-12-04 | カーギル インコーポレイテッド | シクロデキストリン包接複合体及びその製造方法 |
US20070010485A1 (en) * | 2005-07-06 | 2007-01-11 | Jeff Schwegman | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
US20070010478A1 (en) * | 2005-07-06 | 2007-01-11 | Branimir Sikic | Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer |
US20070010487A1 (en) * | 2005-07-06 | 2007-01-11 | Jeff Schwegman | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
US20070010486A1 (en) * | 2005-07-06 | 2007-01-11 | Jeff Schwegman | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
US20070009532A1 (en) * | 2005-07-06 | 2007-01-11 | Branimir Sikic | Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar |
JP2009539978A (ja) * | 2006-06-13 | 2009-11-19 | カーギル インコーポレイテッド | 大粒子シクロデキストリン包接複合体及びその製造方法 |
EP2049083A2 (en) * | 2006-12-27 | 2009-04-22 | Cargill, Incorporated | Stabilisation by preparing cyclodextrin inclusion complexes |
US20080283693A1 (en) * | 2007-05-15 | 2008-11-20 | Evans Michael J F | Propulsion apparatus and system |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5813541A (ja) * | 1981-07-16 | 1983-01-26 | Kureha Chem Ind Co Ltd | エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物 |
US4578383A (en) * | 1982-12-07 | 1986-03-25 | Warner-Lambert Company | CL 1565 antibiotic compounds |
US4663316A (en) * | 1985-06-28 | 1987-05-05 | Warner-Lambert Company | Antibiotic clathrates and pharmaceutical compositions thereof |
DE3608088C2 (de) * | 1986-03-07 | 1995-11-16 | Schering Ag | Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten |
-
1985
- 1985-06-28 US US06/750,718 patent/US4663316A/en not_active Expired - Fee Related
-
1986
- 1986-03-05 DK DK100886A patent/DK100886A/da not_active Application Discontinuation
- 1986-03-07 AU AU54413/86A patent/AU581061B2/en not_active Ceased
- 1986-03-19 CA CA000504449A patent/CA1237125A/en not_active Expired
- 1986-03-25 JP JP61065014A patent/JPS624293A/ja active Pending
- 1986-04-07 ZA ZA862575A patent/ZA862575B/xx unknown
- 1986-05-12 EP EP86303583A patent/EP0206490B1/en not_active Expired - Lifetime
- 1986-05-12 DE DE8686303583T patent/DE3669517D1/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0206490B1 (en) | 1990-03-14 |
EP0206490A2 (en) | 1986-12-30 |
ZA862575B (en) | 1986-11-26 |
CA1237125A (en) | 1988-05-24 |
DE3669517D1 (de) | 1990-04-19 |
EP0206490A3 (en) | 1987-08-19 |
US4663316A (en) | 1987-05-05 |
AU5441386A (en) | 1987-01-08 |
AU581061B2 (en) | 1989-02-09 |
DK100886A (da) | 1986-12-29 |
JPS624293A (ja) | 1987-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK196586D0 (da) | Makrolidantibiotika | |
DK100886A (da) | Antibiotiske clathrater | |
DK406586A (da) | Erythromycinderivater | |
DK109886A (da) | Erythromycinderivater | |
DK246486D0 (da) | Sammenklappelig brandstige | |
ATA155686A (de) | Giesspfannenkopf | |
AT386920B (de) | Maishaecksler | |
ATA122686A (de) | Kettenschloss | |
ATA173385A (de) | Stiegenlift | |
ATA257585A (de) | Ru-deruebungsgeraet | |
BR8501248A (pt) | Sulcador pontiagudo | |
BR6500776U (pt) | Miniploter | |
BR6501198U (pt) | Anel-escova | |
BR6500027U (pt) | Conzeiro | |
BR6500176U (pt) | Pulverizador-cobridor | |
BR6500257U (pt) | Chaveiro-calendario-utilidades | |
BR6500432U (pt) | Polainas | |
BR6500481U (pt) | Omeleteira | |
BR6500483U (pt) | Dialisor | |
BR6500500U (pt) | Bip-alarme | |
BR6500618U (pt) | Palmilha | |
ATA8786A (de) | Heukran | |
BR6500852U (pt) | Churrasqueira-espeto | |
BR6500980U (pt) | Girandola | |
BR6500981U (pt) | Girandola |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |